Integration of the 5G-based Remote Healthcare System in Critical Care

NCT06485518 | Completed

• 2 other identifiers: ky20220304-312023YFC3603100
• Study Type: observational
• Target: 220
• Locations: 1 country
• Sites: 1

Brief Summary

The primary objective of this initial report is to address the following questions: Under what circumstances do clinical teams at satellite locations utilize the 5G RHS? Does the implementation of 5G RHS result in significant clinical enhancements? Furthermore, additional analyses will be conducted to assess specific improvements in various use cases (e.g., emergency room, diagnosis, treatment, task guidance, and medical education) and to examine whether factors such as the expertise of central physicians, patient and physician locations, and the timing of calls influence clinical outcomes.

Conditions

Emergency Medicine; Telemedicine; Augmented Reality

Keywords

Teleconference; Mentoring; Augmented Reality; Emergency; Patient outcome

Outcome Measures

Primary Outcomes (4)

• critical conditions

  For all patients receiving care through the 5G RHS platform during the specified time period, we gathered clinical data from electronic health records (EHRs). This data encompasses information related to critical conditions.

  from July 2022 to June 2023

• background situation

  For all patients receiving care through the 5G RHS platform during the specified time period, we will gather clinical data from electronic health records (EHRs). This data encompasses information related to the emergency situation,

  from July 2022 to June 2023

• reasons for consultation

  For all patients receiving care through the 5G RHS platform during the specified time period, we will gather clinical data from electronic health records (EHRs). This data encompasses information related to reasons for seeking remote consultation (including complex challenges, new medical scenarios, and educational interactions).

  from July 2022 to June 2023

• treatment outcomes

  For all patients receiving care through the 5G RHS platform during the specified time period, we will gather clinical data from electronic health records (EHRs). This data encompasses information related to treatment outcomes.

  from July 2022 to June 2023

Study Arms (1)

5G RHS group

For all patients receiving care through the 5G-based Remote Healthcare System (5G RHS) teleconsultation platform during the specified time period

Behavioral: The 5G RHS group receiving audio-video conferencing and effective data management for decision-making via augmented reality platform RealHealthcare System.

Interventions

The 5G RHS group receiving audio-video conferencing and effective data management for decision-making via augmented reality platform RealHealthcare System. BEHAVIORAL

The 5G RHS group will receive audio-video conferencing and effective data management for decision-making via augmented reality platform. A total of 14 physicians from SRRSH will be participated in the study, offering remote consultations and instant guidance to the physician.

5G RHS group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

In this study, patients with acute chest pain, stroke and trauma will be enrolled in the departments of emergency medicine in the relevant medical community, Branches of Run Run Shaw Hospital, Zhejiang University School of Medicine.

You may qualify if:

• \) Age range (≥18 years old).
• \) Patients with acute chest pain, stroke and trauma were diagnosed in the departments of emergency medicine of the relevant medical community, Branches of Run Run Shaw Hospital, Zhejiang University School of Medicine.
• \) Voluntarily participate in the study and sign the informed consent; If the subject does not have the ability to understand or sign the informed consent, his/her guardian will represent him/her in the informed process and agree to participate in the study; If illiterate, his/her will need a witness to witness the knowledge process and his/her will decide to participate in the study.

You may not qualify if:

• \) Incomplete clinical data.
• \) Minors.
• \) Pregnant women.

Sponsors & Collaborators

• Sir Run Run Shaw Hospital: lead

Study Sites (1)

Sir Run Run Shaw Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310012, China

Location

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Yecheng Jin, M.D

  Sir Run Run Shaw Hospital

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PI

Study Record Dates

• First Submitted: June 25, 2024
• First Posted: July 3, 2024
• Study Start: July 1, 2022
• Primary Completion: June 30, 2023
• Study Completion: August 1, 2023
• Last Updated: July 3, 2024

Record last verified: 2024-07

Locations

CN (1)